Citations

Clear

2117 citation(s) found for "Mayo, Steven".

Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Moraska, Amanda R., Sood, Amit , Dakhil, Shaker R. , Sloan, Jeff A. , Barton, Debra L. , Atherton, Pamela J., Suh, Jason , Griffin, Patricia, Johnson, David , Ali, Aneela, Silberstein, Peter T., Duane, Steven F., Loprinzi, Charles L. , Atherton, Philip J. , Atherton, Pamela J., Atherton, Philip J.

Mayo Clinic

Journal of Clinical Oncology | July 13, 2010 | Volume: 28 | Issue: 23 | Pages: 3673-3679

10.1200/jco.2010.28.1444 | PMID 20625123 Get It

PurposeFatigue is one of the most common symptoms experienced by patients with cancer. This trial was developed to evaluate the efficacy of long-acting methylphenidate for improving cancer-related fatigue and to assess its toxicities.Patients and MethodsAdults with cancer were randomly assigned in a double-blinded manner to receive methylphenidate (target dose, 54 mg/d) or placebo for 4 weeks. The Brief Fatigue Inventory was the primary outcome measure, while secondary outcome measures included a Symptom Experience Diary (SED), the Short Form-36 (SF-36) Vitality Subscale, a linear analog self-assessment, the Pittsburgh Sleep Quality Index, and the Subject Global Impression of Change.ResultsIn total, 148 patients were enrolled. Using an area under the serum concentration-time curve analysis, there was no evidence that methylphenidate, as compared with placebo, improved the primary end point of cancer-related fatigue in this patient population (P = .35). Comparisons of secondary end points, including clinically significant changes in quality-of-life variables and cancer-related fatigue change from baseline, were similarly negative. However, a subset analysis suggested that patients with more severe fatigue and/or with more advanced disease did have some fatigue improvement with methylphenidate (eg, in patients with stage III or IV disease, the mean improvement in usual fatigue was 19.7 with methylphenidate v 2.1 with placebo; P = .02). There was a significant difference in self-reported toxicities (SED), with increased levels of nervousness and appetite loss in the methylphenidate arm.ConclusionThis clinical trial was unable to support the primary prestudy hypothesis that the chosen long-acting methylphenidate product would decrease cancer-related fatigue.
O2‐07‐07: eSNPs within VAMP1 show genetic association with late onset Alzheimer's disease
Zou, Fanggeng, Allen, Mariet , Belbin, Olivia , Talisha, Hunter, Ma, Li , Bisceglio, Gina, Carrasquillo, Minerva M. , Younkin, Curtis, Petersen, Ronald, Younkin, Steven G., Carrasquillo, Minerva M. , Graff, Caroline , Dickson, Dennis W. , Deák, Ferenc

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2010.05.352 Get It

P3‐193: The plasma Aβ42/Aβ40 ratio: A promising biomarker for cognitive decline
Weston, Andrea, Hou, Nanjiang, Graff‐Radford, Neill R. , Satterfield, Suzanne , Harris, Tamara B. , Kuller, Lewis H. , Ayonayon, Hilsa N., Dong, Jingzhong, Younkin, Linda H., Younkin, Steven G. , Yaffe, Kristine , Study, for the Health ABC, Simonsick, Eleanor Marie , Study, for the Health ABC

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_16 | Pages: No page available

10.1016/j.jalz.2010.05.1691 Get It

IC‐P‐145: Effect of APOE4 Status and Alzheimer's Disease on Posterior Cingulate Connectivity
Avula, Ramesh, Przybelski, Scott A. , Younkin, Steven G. , Gunter, Jeff, Petersen, Ronald C. , Machulda, Mary M. , Jones, David T. , McDade, Eric , Vemuri, Prashanthi , Senjem, Matthew L. , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2010.05.160 Get It

S1‐03‐03: The X‐chromosome and Alzheimer's disease
Younkin, Steven G.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2010.05.196 Get It

P2‐380: Effect of APOE4 status and Alzheimer's disease on posterior cingulate connectivity
Avula, Ramesh, Przybelski, Scott A. , Younkin, Steven G., Gunter, Jeff, Petersen, Ronald C. , Machulda, Mary M. , Jones, David T. , McDade, Eric , Vemuri, Prashanthi , Senjem, Matthew L. , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2010.05.1432 Get It

P1‐102: Investigating cis‐SNP/mRNA level associations of candidate Alzheimer genes in different brain regions of patients and controls
Palusak, Ryan, Zou, Fanggeng, Miles, Richard J., Carrasquillo, Minerva M. , Nguyen, Thuy , Petersen, Ronald C. , Graff-Radford, N. R., Younkin, Steven G., Ertekin‐Taner, Nilüfer , Carrasquillo, Minerva M. , Ma, Li , Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.651 Get It

P1‐098: Association of common KIBRA variants with episodic memory and Alzheimer risk
Ertekin‐Taner, Nilüfer , Hirpa, Meron, Nguyen, Thuy , Li, Ma, Zou, Fanggeng, Younkin, Steven G., Petersen, Ronald C. , Graff‐Radford, Neill R. , Pedraza, Otto , Burgess, Jeremy D. , Crook, Julia E. , Pankratz, V. Shane

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.646 Get It

P1‐095: Characterization of brain region‐ and disease‐specific IDE expression in Alzheimer patients and controls
Miles, Richard J., DelleDonne, Anthony, Zou, Fanggeng, Nguyen, Thuy , Bisceglio, Gina, Younkin, Steven G. , Ertekin‐Taner, Nilüfer , Murray, Melissa E. , Ma, Li , Dickson, Dennis W. , Leissring, Malcolm A.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2010.05.643 Get It